BrightSpring Health Services Hits New 52-Week High of $72.21

BrightSpring Health Services, Inc. has reached a significant milestone by hitting a new 52-week high of USD 72.21 on July 13, 2026. This achievement underscores the company's remarkable performance over the past year, with a staggering increase of 521.23%, significantly outpacing the S&P 500's growth of 20.06% during the same period. As a small-cap player in the Pharmaceuticals & Biotechnology industry, BrightSpring has demonstrated strong financial metrics, including a price-to-earnings (P/E) ratio of 41.00 and a return on equity of 10.54%. The company has consistently reported positive results, with a net profit growth of 50.96% as of March 26, and has maintained outstanding performance for six consecutive quarters. BrightSpring's operating cash flow reached a record high of USD 511.52 million, and its debtors turnover ratio stood at an impressive 11.98 times. With a market capitalization of USD 8,193 million and high institutional holdings at 100%, the company is well-positioned within its sector. The stock's journey from a 52-week low of USD 19.01 to its current high reflects its robust market position and operational success.